Lubricoat 0: Filed an IDE to begin a Phase I pilot study of 25 patients. Johnson & Johnson has exclusive worldwide marketing rights for adhesion prevention and

Lifecore Biomedical Inc. (LCBM), Chaska, Minn. Product: Lubricoat 0.5 percent ferric hyaluronate gel Use: Reduce post-operative adhesions after gynecological surgery Status: Filed an IDE to begin a P...